

Q&A with Dr. Michael Cummings
13 snips Apr 5, 2024
Dr. Michael Cummings, an expert in Psychiatry and Schizophrenia, answers listener questions on topics like treating Schizophrenia with long-acting injectables, the effectiveness of clozapine in treatment-resistant cases, and the debate on psychiatric medications' limitations. He also discusses managing breakthrough psychosis, treatment algorithms for depression, and the FDA-approved drug Karaprazine's efficacy in depression treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 6min
Clozapine Use in Treatment-Resistant Schizophrenia
05:43 • 12min
Antipsychotic Medications in Psychiatric Units
17:29 • 5min
The Limitations of Psychiatric Medications
22:49 • 11min
Managing Breakthrough Psychosis & Treatment Algorithms for Depression
34:17 • 10min
Exploring the Efficacy and Risks of Karaprazine in Depression Treatment
44:23 • 12min
Concluding a Q&A Session with Plans for Part Two and Discussion on Information Seeking Process
56:46 • 2min